Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do PPIs diminish Barrett's esophagus length or cancer risk?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 658–659 (2006)Cite this article

boxed-textCooper BT et al. (2006) Continuous treatment of Barrett's oesophagus patients with proton pump inhibitor up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 23: 727–733

PPI treatment does not change the length of Barrett's esophagus, but is associated with the presence of squamous islands; clinicians must collaborate to diminish the neoplastic transformation rate from Barrett's esophagus to esophageal adenocarcinoma

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cameron AJ et al. (1985) The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313: 857–859

    Article  CAS  Google Scholar 

  2. Jemal A et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10–30

    Article  Google Scholar 

  3. Daly JM et al. (1996) National Cancer Data Base report on esophageal carcinoma. Cancer 78: 182–188

    Article  Google Scholar 

  4. Sampliner RE et al. (2001) Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53: 554–558

    Article  CAS  Google Scholar 

  5. Solaymani-Dodaran M et al. (2004) Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 53: 1070–1074

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Assistant Professor of Medicine at Mayo Clinic College of Medicine, Rochester, MN, USA

    Yvonne Romero

Authors
  1. Yvonne Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romero, Y. Do PPIs diminish Barrett's esophagus length or cancer risk?. Nat Rev Gastroenterol Hepatol 3, 658–659 (2006). https://doi.org/10.1038/ncpgasthep0657

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0657

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing